scholarly article | Q13442814 |
P50 | author | Markus Büchler | Q89169 |
Jürgen Weitz | Q65559730 | ||
Christoph Reissfelder | Q86480797 | ||
Moritz Koch | Q90183187 | ||
Heike Elbers | Q117232719 | ||
Nathan M Mollberg | Q117232722 | ||
Gunnar Steinert | Q117232731 | ||
P2093 | author name string | Fang-Ju Lin | |
Alexander Hamm | |||
Maximillian Aigner | |||
P2860 | cites work | Novel function of human RLIP76: ATP-dependent transport of glutathione conjugates and doxorubicin | Q22254720 |
The epsin family of endocytic adaptors promotes fibrosarcoma migration and invasion | Q24295295 | ||
Bridging Ral GTPase to Rho pathways. RLIP76, a Ral effector with CDC42/Rac GTPase-activating protein activity | Q24337472 | ||
Small G protein Ral and its downstream molecules regulate endocytosis of EGF and insulin receptors | Q24534185 | ||
Activation of the RalGEF/Ral pathway promotes prostate cancer metastasis to bone | Q24681479 | ||
Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method | Q25938999 | ||
RLIP76, an effector of the GTPase Ral, interacts with the AP2 complex: involvement of the Ral pathway in receptor endocytosis | Q28141762 | ||
Role of RLIP76 in lung cancer doxorubicin resistance: II. Doxorubicin transport in lung cancer by RLIP76 | Q28182524 | ||
Role of RLIP76 in lung cancer doxorubicin resistance: III. Anti-RLIP76 antibodies trigger apoptosis in lung cancer cells and synergistically increase doxorubicin cytotoxicity | Q28182550 | ||
RLIP, an effector of the Ral GTPases, is a platform for Cdk1 to phosphorylate epsin during the switch off of endocytosis in mitosis | Q28207629 | ||
RalB mobilizes the exocyst to drive cell migration | Q28570438 | ||
RalBP1 is necessary for metastasis of human cancer cell lines | Q30433862 | ||
RalA and RalB: antagonistic relatives in cancer cell migration | Q30437796 | ||
RLIP76 (RalBP1) is an R-Ras effector that mediates adhesion-dependent Rac activation and cell migration | Q30444197 | ||
RALA and RALBP1 regulate mitochondrial fission at mitosis | Q30503960 | ||
Epsin binds to the EH domain of POB1 and regulates receptor-mediated endocytosis | Q33292368 | ||
Signal pathways which promote invasion and metastasis: critical and distinct contributions of extracellular signal-regulated kinase and Ral-specific guanine exchange factor pathways | Q33969356 | ||
Adenosine triphosphate-dependent transport of doxorubicin, daunomycin, and vinblastine in human tissues by a mechanism distinct from the P-glycoprotein | Q34130602 | ||
Divergent roles for RalA and RalB in malignant growth of human pancreatic carcinoma cells. | Q34592093 | ||
Rlip76 transports sunitinib and sorafenib and mediates drug resistance in kidney cancer | Q34729940 | ||
mTOR-independent translational control of the extrinsic cell death pathway by RalA. | Q35131738 | ||
Transport of glutathione conjugates and chemotherapeutic drugs by RLIP76 (RALBP1): a novel link between G-protein and tyrosine kinase signaling and drug resistance | Q35179100 | ||
Ral-GTPases: approaching their 15 minutes of fame | Q35187818 | ||
Ral GTPases: corrupting the exocyst in cancer cells | Q36161656 | ||
Ral: mediator of membrane trafficking | Q36510072 | ||
Regression of melanoma in a murine model by RLIP76 depletion | Q38315672 | ||
The small G-protein RalA stimulates metastasis of transformed cells. | Q38335738 | ||
Increased expression of cdc2 inhibits transport function of RLIP76 and promotes apoptosis | Q39859514 | ||
Activation of RalA is critical for Ras-induced tumorigenesis of human cells. | Q40410788 | ||
RLIP76 transports vinorelbine and mediates drug resistance in non-small cell lung cancer. | Q40459619 | ||
Accelerated metabolism and exclusion of 4-hydroxynonenal through induction of RLIP76 and hGST5.8 is an early adaptive response of cells to heat and oxidative stress | Q43720112 | ||
RLIP76 is a major determinant of radiation sensitivity | Q46604639 | ||
Regression of lung and colon cancer xenografts by depleting or inhibiting RLIP76 (Ral-binding protein 1) | Q80274383 | ||
P433 | issue | 8 | |
P921 | main subject | colorectal cancer | Q188874 |
colorectal carcinoma | Q25493920 | ||
overexpression | Q61643320 | ||
P304 | page(s) | 694-700 | |
P577 | publication date | 2012-06-01 | |
P1433 | published in | Cancer Biology and Therapy | Q2544651 |
P1476 | title | Overexpression of RalBP1 in colorectal cancer is an independent predictor of poor survival and early tumor relapse | |
P478 | volume | 13 |
Q92124212 | CS-PEI/Beclin-siRNA Downregulate Multidrug Resistance Proteins and Increase Paclitaxel Therapeutic Efficacy against NSCLC |
Q36563027 | Complexity of molecular alterations impacts pancreatic cancer prognosis. |
Q39415229 | Endocytic adaptor protein epsin is elevated in prostate cancer and required for cancer progression |
Q42051924 | P300 regulates the human RLIP76 promoter activity and gene expression |
Q39225715 | RLIP76 Inhibition: A Promising Developmental Therapy for Neuroblastoma |
Q37741408 | RLIP76 Targeted Therapy for Kidney Cancer |
Q28294053 | Ral GTPases in tumorigenesis: emerging from the shadows |
Search more.